MarketWatch May 13, 2019
Why pharmaceutical manufacturers’ sky-high profits matter for consumers
Big Pharma eats up a lion’s share of health-care industry profits, according to new first-quarter financial reports — and its dominance has implications for Americans struggling to pay for prescription drugs.
More than half of total industry profits during that period went to the top 10 companies on the list, an Axios quarterly analysis showed. And 90% of those were drug manufacturers: Topping the list of highest-profiting companies were Eli LillyLLY, +0.50% at $4.2 billion, followed by Pfizer PFE, +0.22% at $3.9 billion and Johnson & Johnson JNJ, -0.28% at $3.7 billion.
“It’s not altogether surprising that this many [of the top 10] are pharmaceutical companies,” Stacie Dusetzina, an associate professor of...